Patients with placenta pathology such as praevia, acreta, pre-eclampsia
Patients with bleeding disorders including vonWillebrand disease type I.
Known intolerance to one of the two drugs.
Patients with prolonged QT-time or other serious cardiac diseases.
Liver or kidney failure.
Epilepsy.
Any medical reason why, in the opinion of the investigator, the patient should not participate
